Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences industries.
As a company, we have a single aim: to accelerate our customers’ discovery initiatives through innovation.
By applying our renowned skills for problem-solving, and open communications, Peakdale scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives.
Peakdale Molecular operates on two sites, from our headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
Our range of speciality services includes:
Drug Discovery Support, Nucleoside Chemistry, Materials Chemistry and Research Support.
As part of our dedication to our customers, Peakdale Molecular actively remain a business offering on both the Ariba and Tungsten networks.
In Vitro ADMET, Medicinal Chemistry, Computational Chemistry Services
We place great emphasis on the close interaction between our medicinal chemists, our Computational Chemistry department, our Synthetic Chemistry, and our in vitro ADMET department.
Nucleoside, Nucleotide and Carbohydrate Chemistry.
Peakdale Molecular has particular expertise in the specialist chemistry, purification and analytical techniques required to synthesise these challenging compounds.
Printable Electronics, Nanomaterials, Performance Lubricants & Fuel Additives
In recent years, Peakdale Molecular has rapidly developed experience and expertise in synthetic chemistry for high value materials, and has invested in state-of-the-art equipment to enable materials science projects.
PR&D, Analytical & Purification, Pressure & Hydrogenation Chemistry, Catalogue
Peakdale is able to fully support your research program with experienced scientists and specialist services. All services are available individually (on a Fee For Service basis) or as part of a fully integrated research project (utilising dedicated Full-Time Equivalent scientists).
Customised Assay Design, Highly Repoducible Data and Direct Communications.
At Peakdale Molecular our range of in vitro ADMET models delivers high quality, accurate and reproducible data. With efficient turnaround times, we help accelerate our customers’ drug discovery programmes. In addition to our core assays, we offer clients the option of customised assay design within a completely confidential service.
Concept Life Sciences Group Announces Multimillion Pound Expansion Programme and Rebranding
Concept Life Sciences Group, the business formed in 2014 to break into the international Discovery & Development and Analytical markets, has announced its intention to significantly increase its investment in laboratory capacity and scientific staff. Michael Fort, Concept’s Executive Chairman said “The last two years has seen our company successfully integrate its acquired businesses and […]
Peakdale Announced as Finalists (X2!) for National Retrosynthesis Competition 2017
Congratulations to TWO teams at Peakdale Molecular who have been selected to compete in the final of the 4th National SCI/ RSC Retrosynthesis Competition 2017. From over 100 entries both the ‘Peakdale Chapel Team’ and ‘The Vinylagous Seven’ (based at Peakdale’s Sandwich site), have been shortlisted and will compete against 8 other teams in the final wtaking […]
Metrion Biosciences and Peakdale Molecular sign Integrated Drug Discovery Partnership
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has signed a collaboration agreement with Metrion Biosciences Limited, a specialist ion channel contract research organisation, to offer complete Integrated Drug Discovery Programmes to new and existing and new customers for […]
Peakdale Molecular holds fourth successful ‘Synthesis in Drug Discovery and Development’ symposium in the heart of Liverpool
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, recently held its fourth ‘Synthesis in Drug Discovery and Development’ symposium in Liverpool which explored the complex areas regarding drug discovery and development. The symposium, which took place in the heart […]
Nobel links past, present and future at Peakdale Molecular
Congratulations to Sir Fraser Stoddart and the other recent chemistry Nobel laureates for their research with molecular machines! It is always good to get some recognition for a job well done and here at Peakdale one of our chemists can claim a close involvement with the work. Dr Richard Bissell, with a total of over […]
Peakdale extends its offering by signing collaborative agreement with computational chemistry company, Cresset
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group has signed a collaboration agreement with computational chemistry company, Cresset. By partnering with Cresset, Peakdale has further extended its integrated drug discovery offering. Cresset delivers software and contract research services which […]
Concept Life Sciences Intensifies Its Push into Medicinal Chemistry with new Senior Appointment At Peakdale Molecular
Peakdale Molecular, part of the Concept Life Sciences Group, has appointed Dr Paul Bradley as new Head of Chemistry at the company’s Discovery Park site in Sandwich, Kent. Dr Bradley joins the team with extensive experience across multiple therapeutic areas in drug discovery having previously worked for companies such as Charnwood Molecular Ltd, Pfizer and […]
Peakdale Molecular’s COO Dr Paul Doyle Invited to Judge EDT Industry Leaders Awards 2016
Every year the EDT (Engineering development Trust) hosts the Future Industry Leaders Awards and, this year, Dr Paul Doyle, COO of Peakdale Molecular and CSO of Concept Life Sciences was invited to be on the judging panel for the North West finals. The EDT delivers over 30,000 STEM (science, technology, engineering and mathematics) experiences each […]
Peakdale Adds Two New Team Members to Further Extend its Biological Offering
In order to further extend its biology and integrated drug discovery offering Peakdale Molecular Limited has added two new members to its team. Christopher Doe, PhD, joins as Head of Biology and Sascha Hartmann has joined the business development team as Business Development Manager – Biology Services. Chris, who will be based at Discovery Park […]
Centauri Therapeutics extends research partnership with Peakdale Molecular
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries has signed an agreement to extend its research collaboration with Centauri Therapeutics, a UK based biotechnology company focussed on the discovery and development of novel molecules targeting life threatening diseases. Peakdale provides synthetic and analytical chemistry expertise for the […]